Zeitschriftenaufsatz | 2024 Open Access

Fibrolytic vaccination against ADAM12 reduces desmoplasia in preclinical pancreatic adenocarcinomas.

Autor:in

Chen, Jing; Sobecki, Michal; Krzywinska, Ewelina; Thierry, Kevin; Masmoudi, Mélissa; Nagarajan, Shunmugam; Fan, Zheng; He, Jingyi; Ferapontova, Irina; Nelius, Eric; Seehusen, Frauke; Gotthardt, Dagmar; Takeda, Norihiko; Sommer, Lukas; Sexl, Veronika; Münz, Christian; DeNardo, David; Hennino, Ana; Stockmann, Christian

Publikationen als Autor:in / Herausgeber:in der Vetmeduni

Gotthardt-Pötsch, Dagmar

Journal

Embo Molecular Medicine

Schlagwörter

Animals; ADAM12 Proteinmetabolism; Mice; Cancer Vaccinesimmunologyadministration & dosage; Pancreatic Neoplasmspathologyimmunologytherapyprevention & control; Carcinoma, Pancreatic Ductalimmunologypathologytherapy; Vaccination; Disease Models, Animal; Mice, Inbred C57BL; Cancer-Associated Fibroblastsmetabolismpathologyimmunology; Humans; CD8-Positive T-Lymphocytesimmunology; Fibrosis; Adenocarcinomaimmunologypathologytherapy

Dokumententyp

Originalarbeit

CC Lizenz

CCBY

Open Access Type

Gold

ISSN/eISSN

1757-4676 - 1757-4684

DOI

10.1038/s44321-024-00157-4

WoS ID

WOS:001344993700002

PubMed ID

39478152

Repository Phaidra

o:3794